Peer-reviewed studies showing a link between brain cancer and cellphone radiation are piling up — contradicting a recent World Health Organization (WHO)-led study that claimed there’s no evidence of a link.
South Korean researchers — who analyzed 24 studies and published their report on Oct. 10 in Environmental Health — found significantly higher risks for malignant brain tumors, meningiomaand glioma on the side of the head where cellphones were held.
They also found heavy, long-term cellphone use was linked to an increased risk of glioma.
The South Korean study brings the number of meta-analyses published since 2016 linking cellphone radiation to an increased risk of brain cancer to seven, wrote Joel Moskowitz, Ph.D., on his website.
Moskowitz — who directs the Center for Family and Community Health at the University of California, Berkeley — has conducted and disseminated research on wireless technology and public health since 2009.
“These seven peer-reviewed meta-analytic studies contradict the conclusion of the recent WHO systematic review,” he said.
“Seven studies is a lot and we anticipate more in the future,” Miriam Eckenfels-Garcia, director of Children’s Health Defense’s (CHD) Electromagnetic Radiation (EMR) & Wireless program, told The Defender.
Eckenfels-Garcia said:
“We encourage the WHO to revise its stance, unlikely as this may be. It’s more likely that the WHOand other captured agencies will label non-industry friendly science as misinformation, even if this puts the public further in danger.”
Moskowitz said there’s evidence that the WHO picked industry-biased researchers to conduct its review.
Lennart Hardell, M.D., Ph.D., a leading scientist who found a link between cellphone use and gliomas, agreed. He told The Defender it was “striking” that the South Korean researchers reached a conclusion that directly contradicted the findings by the authors of the WHO study.
Hardell — an oncologist and epidemiologist with the Environment and Cancer Research Foundationwho has authored more than 350 papers, almost 60 of which address wireless radiation — said:
“The WHO study authors should be responsible for their fraudulent behavior violating human health and the environment. Their lack of ethical principles in science gives a ‘green card’ to roll out this technology — and the misinformed layman is the victim.”
Brain tumor rates on the rise in Denmark
The South Korean study was published on the heels of new health data from Denmark showing that central nervous system tumors — including brain tumors — are on the rise.
Denmark is known for its high-quality tracking of cancer cases. So it’s concerning when their data show a clear increase, Mona Nilsson, co-founder and director of the Swedish Radiation Protection Foundation, told The Defender.
The Danish Cancer Registry on Sept. 30 published a report on the number of new cancer cases in Denmark, Nilsson said. It shows that central nervous system tumors have been increasing among both men and women.
Nilsson compared Danish central nervous system cancer diagnosis rates since 1995. “The data show that tumors of the central nervous system, including brain tumors, are increasing and are among the cancers that have increased most rapidly over the past 10 years, between 2014 and 2023.”
The Danish statistics contradict the notion that the rate of brain tumors isn’t on the rise, Nilsson said. “That argument has been used to claim that cellphone use is not linked to an increased risk of brain tumors or cancers in general.”
A 2023 study on brain cancer rates worldwide from 1990-2019 found a significant rise in brain cancer among both men and women in nearly all parts of the world. The study authors noted that this increase was largely seen in Western countries.
In the U.S., overall brain and other nervous system cancer rates haven’t increased, according to the National Cancer Institute. However, there are many reasons tumors may go unreported in the U.S. and other countries, according to Moskowitz.
For instance, Hardell in a 2017 peer-reviewed study found indications of underreporting in the Swedish Cancer Register.
Although the incidence of reported glioma diagnoses in U.S. adults has remained steady, Moskowitz noted in a Sept. 25 webinar, there’s been an increase in glioblastoma — “the most common and most serious malignant brain tumor.”
“We have seen increases in brain tumor incidents among children and young adults,” he added. “Clearly, more research is needed to understand these increases in tumor incidents.”
Ellie Marks told The Defender she and her son founded the California Brain Tumor Association after discovering that her husband’s brain tumor was likely caused by long-term heavy cellphone use.
After the tumor diagnosis in 2008, Marks sent her husband’s medical and phone records to wireless radiation experts, including Hardell. “They got back to me and said, ‘Yes, he is the poster boy for the cellphone brain tumor correlation,’” she recalled.
Her husband survived, but it’s not easy living with a brain tumor — and her husband is far from alone, she said. “I know many others who have experienced brain cancer attributed to their cellphone use.”
FDA turned blind eye to research linking wireless radiation and cancer
The uptick in brain cancer cases isn’t surprising, Eckenfels-Garcia said, and U.S. health agencies saw it coming.
The U.S. Food and Drug Administration (FDA) claims there’s not enough scientific evidence to link cellphone use to health problems, including brain cancer — but it rejected the findings of a $30 million study it commissioned on the topic.
At the FDA’s request, the National Toxicology Program (NTP) did a multi-year study, concluding there was “clear evidence” that male rats exposed to high levels of wireless radiation like that used in 2G and 3G cellphones developed cancerous heart tumors, and “some evidence” of tumors in the brain and adrenal gland of exposed male rats.
When the NTP in 2018 released its findings, the FDA rejected the study and in February 2020, released an unsigned literature review that criticized the study.
Commenting on the increased incidence of brain tumors, Eckenfels-Garcia said, “So essentially this is an ‘I told you so’ moment. This is exactly what happens when our captured government agencies ignore science, as the FDA did with the NTP study.”
Moskowitz said the FDA should have followed up on the NTP study by conducting a formal risk assessment of wireless radiation, but that never happened. Instead, the U.S. government shut down NTP’s follow-up work on its 2018 study.
In April, CHD filed a Freedom of Information Act request with the National Institutes of Health (NIH) for documents and communications related to why the U.S. government stopped the work. The NIH has not responded to the request.